Porter Derrell
Insider CIK 1706400 · ABOS Director · ATRA SVP, Head of Global Commercial · PASG Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABOS Acumen Pharmaceuticals, In | M Exercise deriv | 2026-06-17 | 2026-06-17 | 13,040 | — | $0 | 0 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise | 2026-06-17 | 2026-06-17 | 13,040 | $1.07 | $14.0K | 48,540 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-06-17 | 2026-06-17 | 13,040 | $2.33 | $30.4K | 35,500 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-06-16 | 2026-06-17 | 12,800 | $2.33 | $29.8K | 35,500 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise deriv | 2026-06-15 | 2026-06-17 | 6,460 | — | $0 | 13,040 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-06-15 | 2026-06-17 | 6,460 | $2.35 | $15.2K | 48,300 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise | 2026-06-15 | 2026-06-17 | 6,460 | $1.07 | $6.9K | 54,760 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2026-06-03 | 2026-06-05 | 53,250 | — | $0 | 53,250 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2026-06-03 | 2026-06-05 | 35,500 | — | $0 | 48,300 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 10,539 | — | $0 | 10,539 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2025-06-04 | 2025-06-05 | 19,500 | — | $0 | 19,500 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2025-06-04 | 2025-06-05 | 12,800 | — | $0 | 12,800 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 201,857 | — | $0 | 201,857 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2024-06-10 | 2024-06-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2024-05-21 | 2024-05-23 | 47,693 | — | $0 | 47,693 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2023-06-06 | 2023-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2023-05-25 | 2023-05-26 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2023-01-04 | 2023-01-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 24,000 | — | $0 | 24,000 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2021-05-27 | 2021-05-28 | 33,836 | — | $0 | 33,836 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-03-26 | 2019-03-27 | 10,000 | — | $0 | 31,688 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2019-02-15 | 2019-02-19 | 4,000 | — | $0 | 109,666 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2019-02-15 | 2019-02-19 | 5,909 | $40.00 | $236.4K | 21,688 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2019-02-15 | 2019-02-19 | 4,000 | $14.30 | $57.2K | 27,597 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 24,625 | — | $0 | 24,625 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-02-06 | 2019-02-08 | 12,313 | — | $0 | 23,597 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | F Tax w/h | 2019-02-06 | 2019-02-08 | 1,216 | $38.47 | $46.8K | 11,284 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2018-05-15 | 2018-05-16 | 16,334 | — | $0 | 113,666 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2018-05-15 | 2018-05-16 | 16,334 | $14.30 | $233.6K | 28,834 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-05-15 | 2018-05-16 | 16,334 | $45.02 | $735.4K | 12,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-05-08 | 2018-05-08 | 1,544 | $40.15 | $62.0K | 12,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2018-02-06 | 2018-02-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2018-02-06 | 2018-02-08 | 12,500 | — | $0 | 14,044 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2017-05-10 | 2017-05-11 | 130,000 | — | $0 | 130,000 | SEC↗ |